Search Results - "HATAE, M"

Refine Results
  1. 1
  2. 2

    Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB–IVA cervical cancer with or without immunomodulator Z-100: a JGOG study by Sugiyama, T., Fujiwara, K., Ohashi, Y., Yokota, H., Hatae, M., Ohno, T., Nagai, Y., Mitsuhashi, N., Ochiai, K., Noda, K.

    Published in Annals of oncology (01-05-2014)
    “…Based on the result of our previous study showing better overall survival (OS) at the lower dose (0.2 µg) of immunomodulator Z-100 than higher dose (40 µg) in…”
    Get full text
    Journal Article
  3. 3

    The possible mechanism of preterm birth associated with periodontopathic Porphyromonas gingivalis by Hasegawa-Nakamura, K., Tateishi, F., Nakamura, T., Nakajima, Y., Kawamata, K., Douchi, T., Hatae, M., Noguchi, K.

    Published in Journal of periodontal research (01-08-2011)
    “…Hasegawa‐Nakamura K, Tateishi F, Nakamura T, Nakajima Y, Kawamata K, Douchi T, Hatae M, Noguchi K. The possible mechanism of preterm birth associated with…”
    Get full text
    Journal Article
  4. 4

    Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer by Katsumata, N., Hirai, Y., Kamiura, S., Sugiyama, T., Kokawa, K., Hatae, M., Nishimura, R., Ochiai, K.

    Published in Annals of oncology (01-06-2011)
    “…S-1 is an oral fluoropyrimidine. This phase II study was designed to evaluate the efficacy and safety of S-1 in patients with advanced or recurrent uterine…”
    Get full text
    Journal Article
  5. 5

    Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study by Liao, S Y, Rodgers, W H, Kauderer, J, Darcy, K M, Carter, R, Susumu, N, Nagao, S, Walker, J L, Hatae, M, Stanbridge, E J

    Published in British journal of cancer (19-02-2013)
    “…Background: Lobular endocervical glandular hyperplasia (LEGH) is a rare lesion of the uterine cervix. It has been proposed that LEGH may represent a precursor…”
    Get full text
    Journal Article
  6. 6

    Comparison of adjuvant chemotherapy and radiotherapy in patients with cervical adenocarcinoma of the uterus after radical hysterectomy: SGSG/TGCU Intergroup surveillance by Shimada, M, Nishimura, R, Hatae, M, Hiura, M, Takehara, K, Tase, T, Yamada, H, Kurachis, H, Sugiyama, T, Kigawa, J

    “…The authors conducted this retrospective study to evaluate the efficacy of radiotherapy (RT) for high-risk patients with adenocarcinoma (AC) compared with…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1 by AIDA, H, TAKAKUWA, K, HASEGAWA, K, MIZUNUMA, H, TOYODA, N, KAMATA, H, TORII, Y, SAITO, N, TANAKA, K, YAKUSHIJI, M, ARAKI, T, TANAKA, K, NAGATA, H, TSUNEKI, I, TAKANO, M, TSUJI, S, TAKAHASHI, T, SONODA, T, HATAE, M, TAKAHASHI, K

    Published in Clinical cancer research (01-01-1998)
    “…We analyzed the clinical features of 25 ovarian cancer patients who were associated with germ-line mutations of BRCA1 from four site-specific ovarian cancer…”
    Get full text
    Journal Article
  11. 11

    Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer by Shimada, M, Kigawa, J, Terakawa, N, Yoshizaki, A, Shoji, T, Suzuki, M, Hatae, M, Tsuda, H, Ohwada, M, Sugiyama, T

    “…Doxorubicin, platinum compounds, and taxanes represent the chemotherapeutic agents with the greatest activity in endometrial cancer. We conducted an…”
    Get more information
    Journal Article
  12. 12

    Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy by Sato, S, Yajima, A, Sasaki, H, Mizutani, K, Honjo, H, Yamamoto, K, Ozaki, M, Hasegawa, K, Kudo, T, Yakushiji, M, Hatae, M, Noda, K

    Published in Oncology reports (01-03-2001)
    “…Thymidine phosphorylase (dThdPase) is reportedly identical to platelet-derived endothelial cell growth factor (PD-ECGF). We conducted immunohistochemical…”
    Get more information
    Journal Article
  13. 13

    Evaluation of paclitaxel and carboplatin in patients with endometrial cancer by Nakamura, T, Onishi, Y, Yamamoto, F, Kouno, S, Maeda, Y, Hatae, M

    Published in Gan to kagaku ryoho (01-02-2000)
    “…The purpose of this study was to evaluate the combination of paclitaxel and carboplatin in patients with endometrial cancer who have high-risk histopathologic…”
    Get more information
    Journal Article
  14. 14

    Evidenced-based medicine and future direction of Taxol by Hatae, M, Nakamura, T, Ohnishi, Y

    Published in Gan to kagaku ryoho (01-07-2000)
    “…Taxol was introduced for the clinical treatment of several solid tumor malignancies in the 1990s. It has been established that primary chemotherapy based on…”
    Get more information
    Journal Article
  15. 15

    A case of complete response of metastasis of cervical cancer with a combination of CBDCA and 5'-DFUR by Onishi, Y, Hatae, M

    Published in Gan to kagaku ryoho (01-03-1998)
    “…A 64-year-old woman who had lung metastasis of cervical cancer after radiotherapy and hysterectomy was treated with a combination of CBDCA (300 mg/m2/4 w) and…”
    Get more information
    Journal Article
  16. 16

    Spontaneous Rupture of the Liver in an Uncomplicated Pregnancy by Matsuda, Yoshio, Maeda, Takatsugu, Hatae, Masayuki

    “…Spontaneous liver rupture has been reported during pregnancy secondary to severe pregnancy‐induced hypertension, eclampsia or syndrome of hemolysis, elevated…”
    Get full text
    Journal Article
  17. 17

    Neoadjuvant chemotherapy for advanced epithelial ovarian cancer by Hatae, M, Onishi, Y, Nakamura, T, Yamamoto, H, Kusumoto, M, Matsui, T, Mihara, K, Taniguchi, H

    Published in Gan to kagaku ryoho (01-11-2001)
    “…Primary surgical cytoreduction followed by paclitaxel/carboplatin combination chemotherapy currently is the treatment of choice for advanced epithelial ovarian…”
    Get more information
    Journal Article
  18. 18

    Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study by Noda, K, Hirabayashi, K, Terashima, Y, Ozaki, M, Yakushiji, M, Hatae, M, Kanazawa, K

    Published in Gan to kagaku ryoho (01-08-1997)
    “…A preliminary co-operative study by 7 institutes was conducted to determine the optimal dosage of the combination regimen with nedaplatin, bleomycin and…”
    Get more information
    Journal Article
  19. 19

    A stage IIIc ovarian cancer case of pathological CR after combination treatment with carboplatin and cisplatin by Onishi, Y, Maruyama, H, Kume, K, Hatae, M

    Published in Gan to kagaku ryoho (01-09-1994)
    “…Combination carboplatin and cisplatin (JP) is one of the new strategies for increasing dose intensity and total platinum dose in ovarian cancer chemotherapy…”
    Get more information
    Journal Article
  20. 20

    Evaluation of expected AUC of carboplatin (CBDCA) predicted by Chatelut's formula in comparison with Calvert's by Nakamura, T, Onishi, Y, Kono, T, Maeda, T, Wada, T, Hatae, M

    Published in Gan to kagaku ryoho (01-03-1997)
    “…Several studies have shown that carboplatin AUC seems to correlate with therapeutic outcome and hematologic toxicity. Calvert's formula predicts carboplatin…”
    Get more information
    Journal Article